News Headlines Article

Senators to boost Trump’s proposed ban on PBM rebates
Modern Healthcare

Senators are developing a set of bills to support the Trump administration’s proposed ban on drug rebates for pharmacy benefit managers.

Now that transparency has become Washington’s buzzword for health reform, anti-rebate fervor — backed by pharmaceutical CEOs during last week’s Senate Finance Committee grilling — is ratcheting up in both chambers.

“The whole rebate thing just looks kind of — well it’s hard to understand how the consumer benefits from that,” said Sen. John Cornyn (R-Texas).  “They claim that they sort of spread the benefit in terms of insurance cost, but then it’s hard to get the facts and see exactly where the money goes. I’d prefer a system that’s a little less of a Rubik’s Cube and that’s a little more straightforward.”